Download Epigenetics: Mechanisms, Health Roles, and Emerging Therapeutics and more Study notes Nursing in PDF only on Docsity!
Chapter 7 Study Guide: Epigenetics and Disease I. Foundational Concepts and Mechanisms A. Defining Epigenetics
- Definition: Epigenetics refers to the broad set of processes that modulate how a given set of genomic information gives rise to phenotype.
- Nature of Modification: These are nongenetic modifications (they do not alter the underlying DNA sequence).
- Inheritance: Epigenetic modifications are heritable when a somatic cell divides (mitotic inheritance) or when gametes are produced (germline inheritance).
- Mechanism Categories: Epigenetic mechanisms include chemical modifications to DNA and associated histones, and the production of small RNA molecules. Gene regulation can occur at the level of either transcription or translation.
- Role in Health: Epigenetic modification is critical for fundamental processes like the differentiation of embryonic stem cells and inactivation of one of the two X chromosomes in females. Abnormal epigenetic states are strongly associated with a wide range of pathologies, including metabolic disease and cancers. B. The Four Primary Epigenetic Mechanisms (Fig. 6.1)
- DNA Methylation: ◦ Mechanism: Attachment of a methyl group (CH3) to C5 of a cytosine, typically at a CpG dinucleotide site (cytosine followed by a guanine) in adult somatic cells. ◦ Function/Pathophysiology: Dense DNA methylation is typically associated with histone hypoacetylation. Together, this generally results in transcriptional silencing by excluding transcription factors. ◦ Chromatin State: Dense methylation is characteristic of heterochromatin (a closed state where DNA is tightly bound and transcriptionally inactive).
◦ Disease Link: Aberrant DNA methylation (presence where absent, or absence where present) is associated with misregulation of tumor- suppressor genes and oncogenes.
- DNA Hydroxymethylation: ◦ Mechanism: A hydroxymethyl group, rather than a methyl group, is affixed to the C5 of cytosine. ◦ Function: Most often observed in cells undergoing epigenetic transition. The Tet enzymes convert DNA methylation into hydroxymethylation, which facilitates genome-wide declines in DNA methylation during early embryogenesis. ◦ Disease Link: Abnormally low levels have been linked to neural tube defects and severity in multiple myeloma.
- Histone Modifications: ◦ Mechanism: Chemical changes to histone proteins (the spools around which DNA is coiled). Examples include histone acetylation and deacetylation. ◦ Function: Modification modulates the tightness of the DNA-histone interaction, changing the accessibility of DNA to transcription factors. ◦ Chromatin States: Histone modifications determine whether the DNA is in an euchromatin (open, transcriptionally active) state or a heterochromatin (closed, inactive) state. ◦ Clinical Relevance: Mutations in histone-encoding genes can render cells refractory to differentiation signals.
- Noncoding RNAs (ncRNAs), particularly microRNAs (miRNAs): ◦ Mechanism: Small, hairpin-shaped molecules (approx. 22 nucleotides). They interact with existing messenger RNAs (mRNAs) via partial sequence complementarity. ◦ Function: Typically modulate the stability and translational efficiency of existing mRNAs, often leading to their degradation or impairing ribosomal function. ◦ Disease Link: miRNAs that stimulate cancer development are called oncomirs. Misregulation, such as hypermethylation of miRNA genes, leads to overexpression of their mRNA targets, potentially causing carcinogenesis.
Angelman Syndrome (AS) Same 4 Mb deletion on chromosome 15q Mother Deletion removes the single active copy of a maternally expressed ligase gene (gene product missing). Severe intellectual disability, seizures, ataxic gait. Beckwith- Wiedeman n Syndrome (BWS) Uniparental disomy (two paternal copies of Chr 11) or loss of imprinting Linked to Paternal inheritanc e of Chr 11 Overexpression
of IGF2 (Insulin-like
growth factor 2) because the normally inactive maternal copy is expressed or there are two active paternal copies. Overgrowth condition (large for gestational age), neonatal hypoglycemia, large tongue, increased risk of Wilms tumor. Russell- Silver Syndrome (RSS) Imprinting abnormalities of chromosome 11p15.5 or maternal uniparental disomy Linked to Maternal inheritanc e Downregulation
of IGF2.
Growth retardation, proportionate short stature, small triangular- shaped face.
III. Epigenetics, Cancer, and Environmental Factors A. Epigenetic Pathophysiology in Cancer
- Global Alterations: Tumor cells frequently show genome-wide hypomethylation (decreased methylation), which can increase the activity of oncogenes, and hypermethylation (increased methylation) of the promoter regions of tumor-suppressor genes, decreasing their ability to inhibit tumor formation.
- Specific Examples:
◦ Hypermethylation of the RB1 gene promoter (retinoblastoma).
◦ Hypermethylation of the BRCA1 gene promoter, seen in some inherited
breast cancer cases. Abnormal, dense methylation in the BRCA1 promoter
can be driven by a point mutation in the promoter region.
◦ Hypermethylation of the MLH1 gene promoter (a DNA repair enzyme) in
colon cancer and hereditary nonpolyposis colorectal cancer (HNPCC), leading to DNA damage accrual.
- Screening Potential: Epigenetic screening approaches, sometimes using cell-free DNA from blood draws or bodily fluids like urine or sputum, are being developed to detect atypical methylation patterns associated with specific cancers. B. Epigenetics and Environmental Influences
- Nutrition: Exposure to famine in utero has been linked to increased risk of obesity and diabetes in adulthood, suggesting potential transgenerational
and intergenerational effects mediated by epigenetic changes. The IGF
gene is a possible target of epigenetic modifications arising from nutritional deprivation.
- Ethanol Exposure: The DNA methylation status of specific CpG sites differs between children with and without fetal alcohol spectrum disorder.
- Maternal Care: Studies on rodents suggest that differences in maternal care (e.g., licking and grooming behavior) alter methylation states at the glucocorticoid receptor, potentially linking early stress exposure to adult behavior. C. Epigenetics and Mental Health
- Mental Disorders: Altered epigenetic states are associated with mental health conditions, such as differential methylation profiles at social behavior genes in women with anorexia nervosa. Changes in methylation states at an immune-regulatory locus have been reported in individuals with PTSD.
- Genotype-Environment Interaction: Studies suggest that interactions between genotype and childhood adversity may shape DNA methylation states later in life.
- Fragile X Syndrome (Genetic/Epigenetic): This syndrome is characterized by reduced IQ and cognitive impairment. It results from a
mutation involving the expansion of CG dinucleotide repeats in the FMR
gene promoter (genetic) followed by abnormal epigenetic silencing via the accrual of dense methylation within that expanded region (epigenetic).
Tool/Method Target Modification Mechanism/Principle Bisulfite Conversion
DNA
Methylation (Single Molecule) Chemically converts unmethylated cytosines to uracil, leaving methylated cytosines unchanged, allowing distinction via subsequent sequencing. Chromatin Immunoprecipitation (ChIP) Histone Modification States/Protein Binding Uses antibodies specific to a protein of interest (e.g., a modified histone) to capture protein-DNA complexes, followed by sequencing to map the genomic regions bound by that protein. DNAse Hypersensitivity Testing
DNA
Accessibility States (Chromatin Openness) Uses DNAses (enzymes) to cleave DNA regions that are not protein bound. Hypersensitive (cleaved) sites indicate active transcription. Assay for Transposase- Accessible Chromatin (ATAC- seq)
DNA
Accessibility States (Single Molecule) Uses a transposase to insert adapters/barcodes into "open" chromatin regions, which suggests they are transcriptionally active. Methyl-Sensitive Restriction Enzymes
DNA
Methylation (Population Level) Enzymes that only cleave DNA at cytosines that are free of methylation. can you provide me with a detailed study guide for my advanced pathophysiology class as an aprn student? This detailed study guide is designed for an Advanced Pathophysiology course for an APRN student, emphasizing the molecular mechanisms, clinical relevance, diagnostic tools, and therapeutic targets related to Epigenetics and Disease , as covered in the provided source material.
Advanced Pathophysiology Study Guide: Epigenetics and Disease
I. Core Epigenetic Mechanisms and Definitions A. Foundational Concepts
- Definition: Epigenetics refers to nongenetic modifications that modulate how genomic information leads to phenotype. These processes are generally heritable during somatic cell division (mitotic inheritance) or gamete production (germline inheritance).
- Mechanisms: Epigenetic regulation can occur at the level of either transcription or translation. The mechanisms include chemical modifications to DNA and histones, as well as the production of small RNA molecules.
- Clinical Relevance: Abnormal epigenetic states are strongly associated with a wide range of pathologies, including cancers and metabolic disease. These abnormal states are a focus of preventative efforts and pharmaceutical intervention. B. The Four Key Epigenetic Modifications
- DNA Methylation : ◦ Mechanism: Attachment of a methyl group () to the C5 of cytosine, typically at a CpG dinucleotide site (cytosine followed by a guanine) in adult somatic cells. ◦ Pathophysiology: Dense DNA methylation often coincides with histone hypoacetylation and is typically associated with transcriptional silencing by excluding transcription factors. ◦ Chromatin State: Dense methylation is characteristic of heterochromatin , a condensed, tightly bound state that is transcriptionally inactive. ◦ Aberrant Methylation: Both the presence of dense methylation where it is usually absent, or the absence of methylation where it is usually present, is associated with the misregulation of tumor-suppressor genes and oncogenes.
- DNA Hydroxymethylation : ◦ Mechanism: A hydroxymethyl group, rather than a methyl group, is affixed to the C5 of cytosine.
- Somatic Mosaicism: This random inactivation can cause females whose X chromosomes carry different alleles to exhibit patchy traits (e.g., patchy presence/absence of sweat glands in anhidrotic ectodermal dysplasia). B. Genomic Imprinting Disorders (Parent-of-Origin Dependence)
- Genomic Imprinting: A type of monoallelic expression where the copy inherited from either the mother or the father is permanently inactivated (imprinted) in all somatic cells.
- Imprinting Disorders are characterized by phenotypes that are critically dependent on the parent from whom the mutation is inherited. Syndrome Parental Inheritance Pathophysiology (Molecular Mechanism) Key Pathophysiological Features Prader- Willi Syndrome (PWS) 4 Mb deletion on Chr 15q inherited from the Father Paternally expressed genes in the region are lost (the maternally inherited copies were already imprinted/inactive), resulting in a missing gene product. Short stature, hypotonia, obesity , mild to moderate intellectual disability. Angelman Syndrome (AS) Same 4 Mb deletion on Chr 15q inherited from the Mother Maternally expressed gene (encoding a ligase involved in protein degradation in the brain) is lost, resulting in a missing gene product. Severe intellectual disability , seizures, and ataxic gait. Beckwith- Wiedeman n Syndrome (BWS) Paternal uniparental disomy or loss of imprinting on Chr 11 Overexpression of
IGF2 (Insulin-like growth
factor 2) because the normally inactive maternal copy is expressed, leading to double the active product. Overgrowth condition (large for gestational age), neonatal hypoglycemia, large tongue, and increased risk of Wilms tumor. Russell- Silver Imprinting abnormalities Downregulation of
IGF2.
Growth retardation , proportionate short
Syndrome (RSS) on Chr 11p15. or maternal uniparental disomy stature, small triangular face. III. Epigenetics, Cancer, and Therapeutics (APRN Intervention Focus) A. Epigenetic Pathophysiology in Cancer
- Global Changes: Tumor cells frequently exhibit genome-wide hypomethylation (decreased methylation), which can increase the activity of oncogenes, and hypermethylation of the promoter regions of tumor- suppressor genes, leading to gene silencing.
- Key Tumor Suppressor Silencing: Hypermethylation of promoter regions has been identified in:
◦ RB1 gene (retinoblastoma).
◦ BRCA1 gene (inherited breast/ovarian cancer), where a promoter point
mutation can increase the probability of dense methylation and transcriptional silencing.
◦ MLH1 gene (colon cancer, hereditary nonpolyposis colorectal cancer
[HNPCC]), leading to inactivation of this DNA mismatch repair enzyme and subsequent DNA damage accrual.
- Epigenetic Screening: The ability to screen for abnormal epigenetic states using non-invasive approaches, such as cell-free DNA from blood draws or bodily fluids (urine, sputum), raises the prospect of early cancer detection. B. Therapeutic Strategies for Epigenetic Disease Epigenetic modifications are potentially reversible, making them viable therapeutic targets.
- DNA Demethylating Agents: ◦ Drug: 5-Azacytidine. ◦ Mechanism: A cytosine analogue that, when incorporated into DNA, causes irreversible binding to DNA methyltransferases (DNMTs). ◦ Outcome: Administration reduces DNA methylation density, promoting the passive loss of methylation from replicating DNA and reactivating
significant lifestyle differences (e.g., smoking). These epigenetic changes may be an important part of the aging process. V. Advanced Diagnostic and Research Tools As an APRN student, understanding the principles behind these techniques is crucial for interpreting advanced molecular diagnostics: Tool/Method Target Epigenetic Modification Principle/Mechanism Methyl-Sensitive Restriction Enzymes
DNA
Methylation (Population level) Enzymes cleave DNA only at cytosines that are free of methylation. Bisulfite Conversion
DNA
Methylation (Single molecule) Chemically deaminates unmethylated cytosines to uracil, while methylated cytosines remain unchanged, allowing them to be distinguished via sequencing. Chromatin Immunoprecipitatio n (ChIP) Histone Modification States/Protein Binding Uses an antibody specific to a protein of interest (e.g., modified histone) to capture protein-DNA complexes, followed by sequencing to map the genomic regions bound by that protein. DNAse Hypersensitivity Testing
DNA
Accessibility States (Chromatin Openness) Uses DNAses (enzymes) to cleave DNA regions that are not protein bound. Hypersensitive (cleaved) sites indicate active, open transcription regions. Assay for Transposase- Accessible Chromatin (ATAC- seq)
DNA
Accessibility States (Single molecule) Uses a transposase to insert adapters into "open" chromatin regions , suggesting they are transcriptionally active. Fiber-seq Overall Chromatin Treats chromatin with a methyltransferase that adds methyl
State (Single fiber) groups to adenines within open chromatin regions , yielding paired genetic and epigenetic data from individual molecules.
